Nobilis_logo_vertical_preview.jpg
Nobilis Therapeutics Receives a Notice of Allowance for a Patent Covering Treatment of Psychiatric Disorders With Noble Gases
June 12, 2017 18:57 ET | Nobilis Therapeutics, Inc.
PORTLAND, Ore., June 12, 2017 (GLOBE NEWSWIRE) -- Nobilis Therapeutics announced today that the patent that it had exclusively licensed from Partners HealthCare/McLean Hospital (an affiliate of...
Vapir Enterprises, I
Vapir Enterprises, Inc. Is Granted Its Sixth U.S. Patent
December 07, 2015 05:00 ET | Vapir Enterprises, Inc.
San Jose, CA, Dec. 07, 2015 (GLOBE NEWSWIRE) -- Vapir Enterprises, Inc. (OTCQB: VAPI) (www.vapir.com) (“Vapir” or the “Company”), a developer and manufacturer of revolutionary, state-of-the-art, and...